论文部分内容阅读
目的比较B超、CT、99mTc甲氧基异丁基异腈(MIBI)对于高功能甲状旁腺病灶定位诊断的价值。方法经临床诊断为原发性甲状旁腺机能亢进(简称原发甲旁亢)的23例患者均做了B超检查,20例做了CT扫描,21例进行了99mTcMIBI核素显像。结果23例患者共摘除23枚腺瘤和2枚增生腺体,均经病理诊断证实。B超、CT、99mTcMIBI的灵敏度分别为60%、68%和91%,特异性为97%、97%和100%,准确性为89%、91%和98%。B超与CT无明显差异,99mTcMIBI在灵敏度和准确性方面优于B超和CT,但特异性三者近似。结论99mTcMIBI双时相法对于甲状旁腺腺瘤的定位诊断很有帮助,原发甲旁亢患者首次探查术前进行无创影像定位检查是必要的
Objective To compare the diagnostic value of B-ultrasonography, CT, 99mTc-methoxyisobutylisonitrile (MIBI) in the diagnosis of hyperfunctioned parathyroid lesions. Methods Twenty-three patients with primary hyperparathyroidism (primary hyperparathyroidism) were clinically diagnosed as B-ultrasound, CT scan was performed in 20 cases and 99mTc-MIBI imaging was performed in 21 cases . Results Totally 23 adenomas and 2 proliferative glands were removed in 23 patients, all confirmed by pathological diagnosis. The sensitivity of B-ultrasound, CT, 99mTc-MIBI was 60%, 68% and 91% respectively, and the specificity was 97%, 97% and 100% with accuracy of 89%, 91% and 98% respectively. There was no significant difference between B ultrasound and CT. 99mTcMIBI was superior to B ultrasound and CT in sensitivity and accuracy, but the specificity was similar. Conclusion 99mTcMIBI dual-phase method for the diagnosis of parathyroid adenoma is helpful in the diagnosis of primary hyperparathyroidism for the first time before noninvasive imaging mapping is necessary